M Scavizzi

904 total citations
25 papers, 728 citations indexed

About

M Scavizzi is a scholar working on Genetics, Molecular Medicine and Pharmacology. According to data from OpenAlex, M Scavizzi has authored 25 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 8 papers in Molecular Medicine and 7 papers in Pharmacology. Recurrent topics in M Scavizzi's work include Yersinia bacterium, plague, ectoparasites research (9 papers), Antibiotic Resistance in Bacteria (8 papers) and Pharmacological Effects of Natural Compounds (6 papers). M Scavizzi is often cited by papers focused on Yersinia bacterium, plague, ectoparasites research (9 papers), Antibiotic Resistance in Bacteria (8 papers) and Pharmacological Effects of Natural Compounds (6 papers). M Scavizzi collaborates with scholars based in France, Ivory Coast and Germany. M Scavizzi's co-authors include Y Chabbert, D. H. Bouanchaud, G Gerbaud, Patrick A. D. Grimont, Annie Guiyoule, A. Philippon, Thi Anh Hong Le, Stéphane Bonacorsi, Élisabeth Carniel and Mollaret Hh and has published in prestigious journals such as Journal of Bacteriology, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

M Scavizzi

22 papers receiving 590 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Scavizzi France 13 264 255 238 141 137 25 728
Charlotta Sundin Sweden 19 307 1.2× 355 1.4× 404 1.7× 132 0.9× 283 2.1× 25 990
Joanna Radziejewska‐Lebrecht Poland 20 127 0.5× 364 1.4× 455 1.9× 49 0.3× 277 2.0× 45 997
Asunción Seoane Spain 11 212 0.8× 183 0.7× 226 0.9× 51 0.4× 111 0.8× 15 567
G. Seltmann Germany 12 127 0.5× 96 0.4× 236 1.0× 205 1.5× 166 1.2× 74 720
Monique Malléa France 16 791 3.0× 266 1.0× 391 1.6× 170 1.2× 269 2.0× 23 1.2k
K. Coleman United States 8 305 1.2× 138 0.5× 414 1.7× 187 1.3× 90 0.7× 8 839
S Schlecht Germany 17 76 0.3× 161 0.6× 427 1.8× 78 0.6× 258 1.9× 72 996
D Billot-Klein France 16 414 1.6× 165 0.6× 326 1.4× 335 2.4× 133 1.0× 18 866
Ingegerd Gustafsson Sweden 11 315 1.2× 134 0.5× 343 1.4× 85 0.6× 75 0.5× 18 824
Xuan Wang‐Kan United Kingdom 7 518 2.0× 146 0.6× 382 1.6× 115 0.8× 147 1.1× 7 930

Countries citing papers authored by M Scavizzi

Since Specialization
Citations

This map shows the geographic impact of M Scavizzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Scavizzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Scavizzi more than expected).

Fields of papers citing papers by M Scavizzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Scavizzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Scavizzi. The network helps show where M Scavizzi may publish in the future.

Co-authorship network of co-authors of M Scavizzi

This figure shows the co-authorship network connecting the top 25 collaborators of M Scavizzi. A scholar is included among the top collaborators of M Scavizzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Scavizzi. M Scavizzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Le, Thi Anh Hong, et al.. (2007). Clonal Expansion and Microevolution of Quinolone-Resistant Salmonella enterica Serotype Typhi in Vietnam from 1996 to 2004. Journal of Clinical Microbiology. 45(11). 3485–3492. 45 indexed citations
2.
Péduzzi, Jean, et al.. (2006). Oxacillin-hydrolyzing β-lactamase involved in resistance to imipenem in Acinetobacter baumannii. FEMS Microbiology Letters. 153(2). 333–339. 8 indexed citations
3.
Le, Thi Anh Hong, et al.. (2004). Endemic, Epidemic Clone of Salmonella enterica Serovar Typhi Harboring a Single Multidrug-Resistant Plasmid in Vietnam between 1995 and 2002. Journal of Clinical Microbiology. 42(7). 3094–3099. 21 indexed citations
4.
Scavizzi, M, et al.. (2002). Antimicrobial susceptibility test: from bacterial population analysis to therapy. International Journal of Antimicrobial Agents. 19(1). 9–20. 7 indexed citations
5.
Morand, A, et al.. (1996). Survey of Klebsiella pneumoniae producing extended-spectrum beta-lactamases: prevalence of TEM-3 and first identification of TEM-26 in France. Antimicrobial Agents and Chemotherapy. 40(4). 1027–1029. 24 indexed citations
6.
Ramisse, Françoise, et al.. (1996). Assessment of two penicillins plus beta-lactamase inhibitors versus cefotaxime in treatment of murine Klebsiella pneumoniae infections. Antimicrobial Agents and Chemotherapy. 40(2). 325–330. 13 indexed citations
7.
Morère, Jean‐François, et al.. (1993). [Infectious complications during treatments with interleukin-2].. PubMed. 22(9). 413–6. 1 indexed citations
8.
Scavizzi, M, et al.. (1988). Infections post-operatoires dans les hysterectomies vaginales et prophylaxie antibiotique. Médecine et Maladies Infectieuses. 18(6-7). 313–316. 1 indexed citations
9.
Blaise, M., G Champault, & M Scavizzi. (1988). Antibiotherapie de premiere intention dans les infections hepato-biliaires. Médecine et Maladies Infectieuses. 18(5). 269–273. 2 indexed citations
10.
Scavizzi, M, et al.. (1987). Failure of newer beta-lactam antibiotics for murine Yersinia enterocolitica infection. Antimicrobial Agents and Chemotherapy. 31(4). 523–526. 19 indexed citations
11.
Scavizzi, M & F. Bronner. (1987). [A statistical model for interpreting the antibiogram].. PubMed. 304(12). 325–9. 4 indexed citations
12.
Scavizzi, M, et al.. (1985). In vitro susceptibilities of 126 clinical isolates of Yersinia enterocolitica to 21 beta-lactam antibiotics. Antimicrobial Agents and Chemotherapy. 27(5). 806–811. 39 indexed citations
13.
Scavizzi, M, et al.. (1983). L'antibiothérapie dans les septicémies à Yersinia enterocolitica. Médecine et Maladies Infectieuses. 13(1). 25–30. 4 indexed citations
14.
Scavizzi, M, et al.. (1980). [Bacterial counts in sputum. The value and interpretation in lower respiratory tract infections (author's transl)].. PubMed. 8(5). 393–402. 1 indexed citations
15.
Scavizzi, M, et al.. (1976). A rapid micromethod for the determination of the sensitivity to antibiotics of Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. 2(2). 217–219.
16.
Chabbert, Y & M Scavizzi. (1976). Chelocardin-Inducible Resistance in Escherichia coli Bearing R Plasmids. Antimicrobial Agents and Chemotherapy. 9(1). 36–41. 15 indexed citations
17.
Chabbert, Y, et al.. (1972). Incompatibility Groups and the Classification of fi Resistance Factors. Journal of Bacteriology. 112(2). 666–675. 143 indexed citations
18.
Chabbert, Y, et al.. (1972). Incompatibility Groups andtheClassification of f-Resistance Factors. 1 indexed citations
19.
Hh, Mollaret, et al.. (1971). [Human "Yersinia enterocolitica" septicemia. 17 recent cases].. PubMed. 79(8). 345–8. 51 indexed citations
20.
Bouanchaud, D. H., M Scavizzi, & Y Chabbert. (1968). Elimination by Ethidium Bromide of Antibiotic Resistance in Enterobacteria and Staphylococci. Journal of General Microbiology. 54(3). 417–425. 236 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026